You are viewing the site in preview mode

Skip to main content

Table 4 Multivariate regression analysis for ∆ FABP4

From: Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy

  Regression coefficient SE Standardized regression coefficient (β) P
Age 0.01 0.07 0.01 0.91
Sex (male) − 1.82 1.30 − 0.07 0.16
DPP-4i (anagliptin) − 1.81 1.23 − 0.07 0.14
FABP4 at baseline − 0.31 0.03 − 0.45 < 0.01
∆ Waist circumference 0.29 0.14 0.10 0.04
∆ Creatinine 26.1 5.27 0.25 < 0.01
  1. R2 = 0.294
  2. ∆, change calculated as parameter in 52 weeks minus that in baseline
  3. DPP-4i dipeptidyl peptidase-4 inhibitor, eGFR estimated glomerular filtration rate, FABP4 fatty acid-binding protein 4
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840